Primary Biliary Cirrhosis Flashcards
What are the examination findings of primary biliary cirrhosis?
What are PBC specific features to look out for?
Middle aged female Pruritus, jaundice Hypercholesterolaemia Hepatomegaly +/- splenomegaly Cirrhosis features and complications Metabolic bone disease Proximal myopathy Other autoimmune conditions
Occurs in middle aged female (75-90%)
- Fatigue
- Hyperbilirubinaemia - jaundice, pruritus
- Generalised hyperpigmentation, worse over araes of exfoliation and lichenification - melanin deposit
- Clubbing
- Hypercholesterolaemia - xanthalesma, tendon xanthomata
- Coagulopathy - petechiae, ecchymoses
- Altered sex hormones - spider naevi
-
Hepatomegaly smooth and non-tender +/- hepatic venous hum
8A. Splenomegaly and ascites in portal hypertension - Complications of cirrhosis - hepatic encephalopathy, portal hypertension
- To comment as isolated hepatomegaly or chronic liver disease if unable to elicit additional features
PBC specific features:
1. Metabolic bone disease - kyphosis, fractures, osteoporosis
2. Proximal myopathy/osteomalacia (proximal muscle wasting and weakness)
3. Autoimmune disease
What are the definitive investigations for PBC?
- Serum anti-mitochondrial antibodies - positive in 95%
- 5% negative requiring PBC-specific autoantibodies (sp100, gp210)
- HLA DR8 - Blood tests
A. LFT - cholestatic picture (high GGT, ALP, mild ALT, AST, hyperbilirubinaemia)
- Some patients have AIH overlap ALT > 5x UL
B. IgM - raised
C. Lipid panel - hypercholesterolaemia
D. FBC - mono-pancytopenia - Liver biopsy if required
- Histology: portal tract granuloma, cirrhosis - US HBS, ERCP/MRCP to exclude extra-hepatic cholestasis (stones)
Which drugs can cause cholestasis?
Phenothiazines
Sulphonamides
Penicillins
Rifampicin
Macrolides
Carbamazepine
Androgenic steroids
Diclofenac
What is the management of primary biliary cirrhosis and its complications?
- Involvement of multidisciplinary team
- Supplement of fat soluble vitamins - A, D, E, K
- Treatment of bone disease/osteoporosis (vitamin D, calcium, bisphosphonates)
- Treatment of hypercholesterolaemia
- Treatment of liver disease (ursodeoxycholic acid improves liver biochemistry and slows disease progression)
- Management of pruritis (colestyramine, rifampicin, naltrexone)
- Anti-histamines do not work and may worsen encephalopathy - Management of fatigue (manage co-existent anaemia and hypothyroidism)
- Referral for transplantation (bilirubin >50, refractory fatigue or pruritis)
- Recurrence in graft 15% at 3 years, 30% at 10 years
What are the autoimmune conditions associated with PBC?
What are the features to look out for?
- Graves: goitre, eye signs, thyroid acropachy, pretibial myxedema, hypo/hyperthyroidism
- Sjogren: dry mouth, dry eyes
- RA: symmetrical deforming arthropathy, eye signs
- Scleroderma: telangiectasia, tight shiny skin, sclerodactyly, calcinosis, dystrophic nails
- Dermatomyositis: heliotrope rash, Gottron papules
- Idiopathic ILD: bibasal crepitations
- MG: myasthenic facies, psotsis, proximal weakness, fatigability
- Vitiligo: hypopigmented patches
- Atrophic gastritis: pallor, koilonychia, IDA
What are the typical presentation/features of PBC?
(demography, symptoms and signs)
- Middle aged women (women > men 9:1)
- Fatigue
- Debilitating pruritus and jaundice
- Hypercholesterolaemia
- Liver disease occurs late
Describe the pathogenesis of PBC
- Anti-mitochondrial antibodies (AMA) as molecular mimicry
- Likely from recurrent exposure to E. coli infections
- AM antigens expressed on biliary epithelial cells
- T cell mediated autoimmune attack against biliary cells - Chronic non-suppurative destructive cholangitis
- Necrotising inflammatory process of portal tracts
- Medium and small bile ducts infiltrated with lymphocytes, duct destruction
- Mild fibrosis and bile stasis - Reduction of bile ducts, proliferation of smaller bile tubules
- Increased fibrosis, expansion of periportal fibrosis to bridging fibrosis - Development of cirrhosis
What are the complications of PBC?
- Malabsorption - osteomalacia, coagulopathy
- Thromboembolism - anti-thrombin antibodies
- Sicca syndrome (70%)
- Cirrhosis, portal hypertension and complications
- Hepatocellular carcinoma (20x risk)